News
BHC
4.430
-0.45%
-0.020
Weekly Report: what happened at BHC last week (0713-0717)?
Weekly Report · 5d ago
Weekly Report: what happened at BHC last week (0706-0710)?
Weekly Report · 07/13 10:22
REFILE-BUZZ-Bausch + Lomb stops glaucoma eye drop development, US-listed shares drop
Reuters · 07/09 21:15
Bausch + Lomb releases Phase 2 BL1107 glaucoma study update
PUBT · 07/09 20:31
Bausch Health to report Q2 results after market close, host conference call
PUBT · 07/07 11:13
Stocks in play: Bausch Health Companies Inc.
Barchart · 07/07 09:35
Bausch Health Announces Quebec Provincial Listing Of Prokedi For Treatment Of Schizophrenia In Adults
Benzinga · 07/06 11:22
Bausch + Lomb to report Q2 results, host investor call
PUBT · 07/06 11:15
Bausch Health Canada says Quebec lists PrOKEDI on public drug formulary for schizophrenia
PUBT · 07/06 11:07
QUÉBEC IS THE FIRST PROVINCE TO LIST (PR)OKEDI(MC) (EXTENDED-RELEASE INJECTABLE SUSPENSION OF RISPERIDONE) ON THE PUBLIC DRUG REIMBURSEMENT FORMULARY FOR THE TREATMENT OF SCHIZOPHRENIA
Reuters · 07/06 11:00
Weekly Report: what happened at BHC last week (0629-0703)?
Weekly Report · 07/06 10:26
*Bausch Health: Goettler's Resignation Wasn't Result of Any Disagreement
Dow Jones · 07/01 20:18
Bausch Health director Michael Goettler resigns after Knoa Pharma CEO appointment
PUBT · 07/01 20:17
*Bausch Health: Goettler Resigned From the Board in Connection With Appointment as Pres and CEO of Knoa Pharma >BHC
Dow Jones · 07/01 20:17
MICHAEL GOETTLER RESIGNS FROM BAUSCH HEALTH'S BOARD OF DIRECTORS
Reuters · 07/01 20:15
*Michael Goettler Resigns From Bausch Health's Bd of Directors
Dow Jones · 07/01 20:15
Press Release: Michael Goettler Resigns from Bausch Health's Board of Directors
Dow Jones · 07/01 20:15
Bausch + Lomb survey links dry eye symptom treatment to improved quality of life, lower anxiety
PUBT · 07/01 11:01
Weekly Report: what happened at BHC last week (0622-0626)?
Weekly Report · 06/29 10:21
Weekly Report: what happened at BHC last week (0615-0619)?
Weekly Report · 06/22 10:30
More
Webull provides a variety of real-time BHC stock news. You can receive the latest news about Bausch Health Companies Inc through multiple platforms. This information may help you make smarter investment decisions.
About BHC
Bausch Health Companies Inc. is a global, diversified pharmaceutical company. The Salix segment includes sales in the U.S. of GI products. The International segment includes sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment includes global sales of Solta Medical aesthetic medical devices. The Diversified segment includes sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, dermatology products, generic pharmaceutical products and dentistry products. The Bausch + Lomb segment includes global sales of Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products. Its drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in AH patients.